CompoAtlas

pukka wholistic ashwagandha (2018.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000686/2018
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
EZOTERIKA, SIA
Manufacturer
Pukka Herbs Ltd.
Origin
Latvija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
2 kapsulas dienā
Published pack size
kapsulas pa 736mg
Published packaging
30 vai 60 kapsulas

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
Vitānijas saknes pulverisplants ; Vitānijas saknes pulveris ; Withania somnifera ; 761,40 ; mgwithania somniferaPlant
Vitānijas saknes holistiskais ekstraktsplants ; Vitānijas saknes holistiskais ekstrakts ; Withania somnifera ; 360 ; mgwithania somniferaPlant
Jūras aļģes lapoņa pulverisplants ; Jūras aļģes lapoņa pulveris ; Ascophyllum nodosum ; 57,60 ; mgascophyllum nodosumPlant
Ingvera sakneņu pulverisplants ; Ingvera sakneņu pulveris ; Zingiber officinale ; 12 ; mgzingiber officinalePlant
Zilaļģes jeb spirulīnas visas aļģes pulverisplants ; Zilaļģes jeb spirulīnas visas aļģes pulveris ; Arthrospira platensis ; 9 ; mgNot recognisedRole not identified
Silīcija dioksīds (E551)otherIngredients ; Silīcija dioksīds (E551)Listed as food additive E 551 (EU Union list)Role not identified
Hidroksipropilmetilceluloze (E464) (kapsulas apvalks)otherIngredients ; Hidroksipropilmetilceluloze (E464) (kapsulas apvalks)Listed as food additive E 464 (EU Union list)Role not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Lielbritānija

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vitānijas saknes pulveris
    Read the warning, when it applies and the studies cited

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    Sources cited by Health Canada (3)
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    Sources cited by Health Canada (3)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
    • Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.

    Health Canada monograph dated 28 February 2025

  • Ingvera sakneņu pulveris
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “pukka wholistic ashwagandha (2018.)”, https://compoatlas.com/en/supplements/latvia/7630-pukka-wholistic-ashwagandha-2018, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line